Filing Details

Accession Number:
0000711377-10-000019
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-10-04 20:01:28
Reporting Period:
2010-10-01
Filing Date:
2010-10-04
Accepted Time:
2010-10-04 20:01:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187556 M Lon Bohannon Neogen Corp
620 Lesher Place
Lansing MI 48912
President & Coo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-10-01 12,934 $9.02 363,976 No 4 M Direct
Common Stock Disposition 2010-10-01 12,934 $32.97 351,042 No 4 S Direct
Common Stock Acquisiton 2010-10-01 196 $13.55 351,238 No 4 M Direct
Common Stock Disposition 2010-10-01 196 $32.97 351,042 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Options (Right to buy) Disposition 2010-10-01 12,934 $0.00 12,934 $9.02
Common Stock Common Stock Options (Right to buy) Disposition 2010-10-01 196 $0.00 196 $13.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,964 2011-11-03 No 4 M Direct
69,408 2012-08-09 No 4 M Direct
Footnotes
  1. The options were granted 11/3/06 as NQ options and vested 20% yearly thereafter
  2. The options were granted 8/9/07 as NQ options and vested 20% yearly thereafter